Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s): INNPF

Healthcare

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more

Recent & Breaking News (CSE:INNO)

Former Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee

Newsfile July 14, 2021

Innocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms

Newsfile July 9, 2021

Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement for Poland

Newsfile July 1, 2021

Innocan Pharma's CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of the Appearance of Wrinkles by up to 28.8% in 4 Weeks of Clinical Study

Newsfile June 24, 2021

Innocan Pharma Corporation to Webcast Live at Life Sciences Investor Forum June 24th

GlobeNewswire June 21, 2021

Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness Solution

Newsfile June 16, 2021

Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturizer and Lubricant Treatment

Newsfile June 14, 2021

InnoCan Pharma tests (CSE:INNO) Liposome Platform Technology for CBD

Trevor Abes June 11, 2021

Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release of CBD into Bloodstream in Recent Animal Study

Newsfile June 11, 2021

Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference

Newsfile June 9, 2021

Innocan Pharma’s (CSE:INNO) CBD loaded liposome platform technology receives positive results

Brieanna McCutcheon May 14, 2021

Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study

Newsfile May 14, 2021

Innocan Pharma Engages Lytham Partners to Lead Investor Relations and Shareholder Communication Program

Newsfile May 10, 2021

Innocan Pharma Announces Trading on the OTCQB Venture Market and DTC Eligibility of Its Common Shares in the United States

Newsfile May 6, 2021

Innocan Pharma and Polyflame Announce an Exclusive Distribution Agreement in France

Newsfile April 22, 2021

Richard Serbin, Former Johnson & Johnson's VP and a Leading Global Strategy Advisor in the Healthcare Industry, to Join Innocan Pharma's Scientific Advisory Committee

Newsfile April 6, 2021

Innocan Reports Q4 2020 Financial Results

Newsfile April 1, 2021

Dr. Mitchell Kline joins Innocan Pharma’s (CSE:INNO) Scientific Advisory Committee

John Ballem March 23, 2021

Leading American Dermatologist Dr. Mitchell Kline to Join Innocan Pharma's Scientific Advisory Committee

Newsfile March 23, 2021

Innocan Pharma Announces Proceeds of CDN $ 3.1M from the Exercise of Warrants Since January 1, 2021

Newsfile March 16, 2021